Boehringer's Barner On Leading – And Leaving – A Singular Company
This article was originally published in Scrip
Executive Summary
In June, Prof. Dr Andreas Barner will stand aside from the helm of Boehringer Ingelheim. He spoke to Scrip's Eleanor Malone about the company and his legacy.